Literature DB >> 25268180

Correlation of proteinuria with podocyte foot process effacement in IgA nephropathy: an ultrastructural study.

Rohit Tewari1, Ritambhra Nada, Charan Singh Rayat, Dibyajyoti Boruah, Puja Dudeja, Kusum Joshi, Vinay Sakhuja.   

Abstract

BACKGROUND: Proteinuria is an uncommon clinical manifestation of IgA nephropathy and is usually seen in cases with severe lesions like endocapillary proliferation. However, it is occasionally seen even with cases with mild glomerular manifestations and may even be of nephrotic range. PREDICTOR: Podocyte foot process effacement. OUTCOME: Severity of proteinuria. MEASUREMENTS: Podocyte foot process effacement was measured. Morphometric analysis was performed on transmission electron microscope images using a computerized digital photomicrograph system (BioWizard 4.2 Image analysis software, New Delhi, India). Proteinuria was measured quantitatively assigned into five grades.
RESULTS: It was found that as the extent of proteinuria increased, the effacement ratio also increased, and this was most significant between "no" proteinuria and the rest of the categories.
CONCLUSION: Nephrotic presentation in IgA nephropathy is a known phenomenon and in certain cases may show near normal glomerular morphology with severe foot process effacement on EM being the only significant finding to explain the proteinuria. Proteinuria in these cases shows a significant correlation with degree of foot process effacement. Renal biopsy is important in these cases because they are known to have a better prognosis and are usually steroid responsive.

Entities:  

Keywords:  Foot process effacement; IgA nephropathy; proteinuria

Mesh:

Year:  2014        PMID: 25268180     DOI: 10.3109/01913123.2014.960543

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  8 in total

1.  How many podocyte autophagosomes are there in immunoglobulin A nephropathy and idiopathic membranous nephropathy?

Authors:  Shikai Liang; Juan Jin; Jianguang Gong; Bo Lin; Yiwen Li; Qiang He
Journal:  Int Urol Nephrol       Date:  2016-08-31       Impact factor: 2.370

2.  Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.

Authors:  Ling Sun; Lu-Xi Zou; Yu-Chen Han; Dong-Dong Zhu; Ting Chen; Jie Wang
Journal:  Clin Exp Nephrol       Date:  2019-12-07       Impact factor: 2.801

Review 3.  Implications of Sphingolipid Metabolites in Kidney Diseases.

Authors:  Shamroop Kumar Mallela; Sandra Merscher; Alessia Fornoni
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

4.  Loss of Roundabout Guidance Receptor 2 (Robo2) in Podocytes Protects Adult Mice from Glomerular Injury by Maintaining Podocyte Foot Process Structure.

Authors:  Anna Pisarek-Horowitz; Xueping Fan; Sudhir Kumar; Hila M Rasouly; Richa Sharma; Hui Chen; Kathryn Coser; Crystal T Bluette; Dinesh Hirenallur-Shanthappa; Sarah R Anderson; Hongying Yang; Laurence H Beck; Ramon G Bonegio; Joel M Henderson; Stephen P Berasi; David J Salant; Weining Lu
Journal:  Am J Pathol       Date:  2020-03-24       Impact factor: 4.307

5.  Quantitative proteomics analysis of lysine 2-hydroxyisobutyrylation in IgA nephropathy.

Authors:  Shaoying Huang; Fengping Zheng; Hua Lin; Xianqing Zhou; Huixuan Xu; Cantong Zhang; Weier Dai; Berthold Hocher; Xinzhou Zhang; Donge Tang; Yong Dai
Journal:  Clin Proteomics       Date:  2021-02-08       Impact factor: 3.988

6.  Great prognosis of concurrent anti-GBM disease and IgA nephropathy in a young woman: A case report.

Authors:  Fu Shaojie; Su Sensen; Huang Jingda; Wang Luyu; Zhang Fei; Yu Jinyu; Xu Zhonggao; Wu Hao
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

7.  Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy.

Authors:  Shikai Liang; Juan Jin; Xiaogang Shen; Xinxin Jiang; Yiwen Li; Qiang He
Journal:  Exp Ther Med       Date:  2018-07-19       Impact factor: 2.447

8.  In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.

Authors:  Crislaine Aparecida da Silva; Maria Luíza Gonçalves Dos Reis Monteiro; Liliane Silvano Araújo; Monise Gini Urzedo; Lenaldo Branco Rocha; Marlene Antônia Dos Reis; Juliana Reis Machado
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.